Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations
Ogo I Egbuna, Edward M Brown
Kidney International
|
January 23, 2026
ICD-10 codes for APOL1-mediated kidney disease
Barry I Freedman, Barbara S Gillespie, Ogo I Egbuna
Clinical Transplantation
|
July 25, 2007
Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure
Ogo I Egbuna, Jeremy G Taylor, David A Bushinsky, et al.
Current Medical Research and Opinion
|
November 8, 2016
Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers
Rajeshree S Joshi, Ogo I Egbuna, Alex S Cairns, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 3, 2009
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
Lakshmi Kantham, Steven J Quinn, Ogo I Egbuna, et al.
Transplantation
|
September 11, 2009
Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation
Ogo I Egbuna, Roger B Davis, Robyn Chudinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 15, 2011
Effects of denosumab on fracture and bone mineral density by level of kidney function
Sophie A Jamal, Osten Ljunggren, Catherine Stehman-Breen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations
Ogo I Egbuna, Edward M Brown
Kidney International
|
January 23, 2026
ICD-10 codes for APOL1-mediated kidney disease
Barry I Freedman, Barbara S Gillespie, Ogo I Egbuna
Clinical Transplantation
|
July 25, 2007
Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure
Ogo I Egbuna, Jeremy G Taylor, David A Bushinsky, et al.
Current Medical Research and Opinion
|
November 8, 2016
Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers
Rajeshree S Joshi, Ogo I Egbuna, Alex S Cairns, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 3, 2009
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
Lakshmi Kantham, Steven J Quinn, Ogo I Egbuna, et al.
Transplantation
|
September 11, 2009
Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation
Ogo I Egbuna, Roger B Davis, Robyn Chudinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 15, 2011
Effects of denosumab on fracture and bone mineral density by level of kidney function
Sophie A Jamal, Osten Ljunggren, Catherine Stehman-Breen, et al.
Page
of 1